Analyses of Off-Target Effects on Cardiac and Skeletal Muscles by Berberine, a Drug Used to Treat Cancers and Induce Weight Loss.
Berberine 對心臟和骨骼肌的非靶向效應分析:一種用於治療癌症和促進減重的藥物。
Cytoskeleton (Hoboken) 2024-11-11
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism.
抗體阻斷活性素II型受體在 GLP-1 受體激動過程中保護骨骼肌肉質量並增進脂肪減少。
Mol Metab 2024-02-24
Uncovering the potential molecular mechanism of liraglutide to alleviate the effects of high glucose on myoblasts based on high-throughput transcriptome sequencing technique.
揭示利拉魯肽減輕高葡萄糖對肌原細胞影響的潛在分子機制:基於高通量轉錄體測序技術。
BMC Genomics 2024-02-14
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
肌肉質量與胰高血糖素樣肽-1受體激動劑:對體重減輕的適應性或不適應性反應?
Circulation 2024-10-14
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation.
體重減輕對無脂肪質量、肌肉、骨骼和造血健康的影響:對新興藥物療法在脂肪減少和保護瘦體重方面的啟示。
Metabolism 2024-10-31
Protective effect of maltol on pathological response of cardiomyocyte in dystrophic mice.
麥芽酮對肌營養不良小鼠心肌細胞病理反應的保護作用。
Korean J Physiol Pharmacol 2024-11-14
The Etiology of Reduced Muscle Mass with Surgical and Pharmacological Weight Loss and the Identification of Potential Countermeasures.
手術與藥物減重導致肌肉質量減少的病因及潛在對策的識別。
Nutrients 2025-01-11
The Effects of Glucagon-Like Peptide-1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review.
Glucagon-Like Peptide-1 受體激動劑對骨骼肌線粒體功能的影響:系統性回顧。
J Cachexia Sarcopenia Muscle 2025-01-16